FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/055952 [Registered on: 01/08/2023] Trial Registered Prospectively
Last Modified On: 26/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To evaluate effect of Tiladi Kwatha Orally & Shatpushpa Siddha Taila Nasya in the treatment of Pushpaghni (PCOS) 
Scientific Title of Study   "CLINICAL STUDY OF TILADI KWATHA ORALLY AND SHATPUSHPA SIDDHA TAILA NASYA IN THE MANAGEMENT OF PUSHPAGHNI” (PCOS) 
Trial Acronym  CSTKSTN 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanoor Bano 
Designation  P.G. Scholar 
Affiliation  Post Graduate Institute of Ayurveda, DSRRAU Jodhpur  
Address  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
Jodhpur
RAJASTHAN
342037
India 
Phone  9672256870  
Fax    
Email  sanurbano721@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rashmi Sharma 
Designation  Associate Professor  
Affiliation  Post Graduate Institute of Ayurveda, DSRRAU Jodhpur  
Address  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
Jodhpur
RAJASTHAN
342037
India 
Phone  9166607559  
Fax    
Email  vd_rashmi11@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanoor Bano 
Designation  P.G. Scholar 
Affiliation  Post Graduate Institute of Ayurveda, DSRRAU Jodhpur  
Address  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
Jodhpur
RAJASTHAN
342037
India 
Phone  9672256870  
Fax    
Email  sanurbano721@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurved, Jodhpur Rajasthan  
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurved, Jodhpur Rajasthan 
Address  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Dr Sanoor Bano  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanoor Bano  Post Graduate Institute of Ayurved Jodhpur  P.G Department of Prasuti Tantra evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwad, Jodhpur, RAJASTHAN 342037 India
Jodhpur
RAJASTHAN 
9672256870

sanurbano721@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Post graduate institute of Ayurveda Jodhpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E282||Polycystic ovarian syndrome. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-nasyam, नस्यम् (Procedure Reference: Sharangdhar Samhita Madhyam khanda, Procedure details: Shatpushpa Siddha Tail will be made by Reference of “Sneha Kalpana” in Sharangdhar Samhita Madhyam khanda. 1 part of Kalka darvya and 4 parts of tail and 16 parts of Kwatha will be mixed and it will be heated till only Sneha (oil) remains. )
(1) Medicine Name: Shatpushpa Siddha Taila, Reference: का. स/. शतपुष्पा शतावरी कल्प/, Route: Nasal, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 2(drops), Frequency: od, Duration: 42 Days
2Intervention ArmDrugClassical(1) Medicine Name: Tiladi Kwatha, Reference: ग० नि०ष०ख०1/59, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 42 Days, anupAna/sahapAna: Yes(details: -Koshan Jala), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Patients diagnosed cases of PCOS by the Rotterdam criteria.
2.Age: Patients aged between 16-40 years.
3. The patients who are fit for the Nasya procedure were only considered for the study.
4. Patients willing for Informed consent.
 
 
ExclusionCriteria 
Details  •Patients having any other disease causing oligomenorrhea and anovulation excluding PCOD on the above criteria.
•Patients using oral contraceptive pills.
•Pregnant and lactating women.
•Patients suffering from thyroid abnormalities, Hyperprolactinemia, adrenal hyperplasia etc.
•Patients with any organic reproductive system abnormalities like hydrosalpinx, endometriosis, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).
•Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy.
•Patients who are contraindicated for Nasya like, Nasal polyp etc.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Assessment for Menstrual abnormality (Oligomenorrhea)
2.Assessment for Hypomenorrhea
3.Assessment for Menorrhagia
4.Pain associated with Menstruation
5.Assessment of Acne (according to acne grading)
6.Assessment of Hirsutism (on the basis of site)
 
for 8 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
•Percentage improvement in reduction of ovarian size, volume, stromal pattern
• Percentage improvement in biochemical values.
•Percentage improvement in hormonal assays.
•Weight reduction as assessed by reduction in Body weight, BMI 
60 DAYS 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is single group clinical study, open label to evaluate the effect of nasya with shatpushpa taila and tiladi kwatha in the management of Pushpughni (PCOS). The primary outcome of this treatment to reduce menstrual abnormality (Oligomenorrhea) ,  hypomenorrhea,  Menorrhagia, Pain associated with Menstruation ,Assessment of Acne (according to acne grading) , Hirsutism (on the basis of site). 
Close